Moreover, when the group of women who achieved a pCR was combined with those with ALDH1(−) tumors at the end of NAC, this group also derived a highly significant survival advantage.
← all excerpts
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.
1
—
—